Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® GI Monitor assay on the UniCel® DxI 800 Immunoassay System

P Stieber, Rafael Molina, Massimo Gion, Axel M. Gressner, Frédéric Troalen, Stefan Holdenrieder, José Maria Augé, Matelda Zancan, Matthias Wycislo, Véronique JarrigeClinical 2008 · DOI

Abstract

The Access GI Monitor provides very good methodological characteristics and demonstrates an excellent analytical and clinical correlation with the Elecsys CA19-9. The GI Monitor shows the best diagnostic accuracy in pancreatic cancer. Our results also suggest a clinical value of the GI Monitor in other cancers.
BibTeX
@inproceedings{stieber2008alternative,
  author = {P Stieber and Rafael Molina and Massimo Gion and Axel M. Gressner and Frédéric Troalen and Stefan Holdenrieder and José Maria Augé and Matelda Zancan and Matthias Wycislo and Véronique Jarrige},
  title = {{Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® GI Monitor assay on the UniCel® DxI 800 Immunoassay System}},
  booktitle = {Clinical},
  year = {2008},
  doi = {10.1515/cclm.2008.126},
}
Figure